Avadel Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for patients with sleep disorders, specifically targeting conditions like narcolepsy and obstructive sleep apnea
The company leverages its proprietary drug delivery technology to create novel formulations designed to improve patient outcomes and enhance medication adherence. Avadel aims to address unmet medical needs through its advanced therapies while also pursuing strategic partnerships and collaborations to expand its product offerings and reach in the pharmaceutical market.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Shares of RxSight, Inc. (NASDAQRXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.
U.S. stocks traded mixed, with the Dow Jones dropping around 30 points on Monday. Here are some big stocks recording losses in today’s session. Protagonist Therapeutics, Inc. (NASDAQPTGX) shares dipped 36.4% to $17.60.
